Press Release
-
2023 Year End Press Briefing
- December 18, 2023
- Posted by: nafdacadmin
- Category: Press Release
No Comments -
DG’S Remarks on the WHO Prequalification of NAFDAC’s Central Drug Control Laboratory (CDCL), Yaba
- December 14, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
The Positive Impact Of Global Fund And Other Partners On NAFDAC’s Regulatory System Strengthening
- November 6, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Keynote Speech by Prof. Mojisola Christian Adeyeye on Fighting the Scourge of Illicit Trade in the Pharma Industry: The Role Of Communication
- October 26, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Press Briefing on Nigeria Export Rejects and Continued Efforts of NAFDAC to Change the Narrative: NAFDAC Met With UK Food Standard Agency (FSA)
- October 17, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Joint Press Briefing: Approval by NAFDAC on use of Gardasil Vaccine as Single Dose in the Routine Immunization Against Cervical Cancer
- October 17, 2023
- Posted by: nafdacadmin
- Category: Press Release, Uncategorized
-
Collaboration between NAFDAC and National Health Insurance Authority
- October 12, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Press Briefing On Reported Decline In Pharmaceutical Imports Into Nigeria
- September 15, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Press Briefing on the Illegal Importation, Sales and Distribution of Crusader Soaps Containing Mercury in Nigeria
- September 15, 2023
- Posted by: nafdacadmin
- Category: Press Release
-
Press Briefing: Re-NAFFDAC approves GLUCOZIL, AAU’s herbal medicine for diabetes
- August 29, 2023
- Posted by: nafdacadmin
- Category: Press Release